Thanks for choosing mmm-online.com Sign up for your FREE account now and join the thousands of other healthcare marketing professionals who rely on us for all the latest industry news and innovative ideas for direct and digital strategy. Simply fill out the fields below.

Email*

Password*

Keep me logged in Forgot your password?

Email*

Noah Pines

Email Noah Pines

Recent Articles

Therapeutic Focus 2013: Rheumatology

May 01, 2013

Noah Pines on the roll-out of Pfizer's new RA pill Xeljanz, a biologic maker's response, and how the upstart may prompt a move away from needle-based therapies

Therapeutic Focus 2013: Respiratory

April 01, 2013

As specialty drugs enter the respiratory market, alongside successors to current blockbusters, Noah Pines looks at how big pharma aspires to sustain sales, and how the new entrants are making inroads

Coming face-to-face with advanced cancer

March 22, 2013

A relative's illness challenges a pharma consultant's view of industry progress.

Therapeutic Focus 2013: Metabolic

March 01, 2013

The prevalence of diabetes and obesity is still high, despite piecemeal attempts at treating them. Among drug makers' latest efforts: pills that address both at once. Noah Pines reports

Therapeutic Focus: Rare Diseases

February 01, 2013

Companies are looking carefully at the rare disease area now. But there's a steep curve, as firms in this burgeoning space face a host of unique challenges

Anderson's 360: Signs of Life

November 30, 2012

With some of the biggest patent expiries due to pass in 2013, the next two years will be important in terms of pharma's return to growth, says Sanford Bernstein's Dr. Tim Anderson in a discussion with Noah Pines

BMS, Abbott HCV pill data suggest competition for Gilead

October 16, 2012

Abbott and BMS peeled back the curtain on some impressive clinical trial results, suggesting that Gilead may have some competition in the sprint for an all-oral anti-HCV treatment.

Op/Ed: Meningitis crisis and the threat to pharma

October 10, 2012

The deadly meningitis outbreak highlights the threat not only to public health, but also to the pharma industry, posed by the largely unregulated practice of pharmacy compounding.

Boehringer Ingelheim prepares to launch oncology franchise

October 02, 2012

Boehringer Ingelheim has long been associated with treatments for stroke prevention, COPD and HIV/AIDS, but not cancer. That's about to change, if a cornucopia of 13 abstracts presented at the European Society for Medical Oncology (ESMO) is any evidence.

Analysis sounds alarm on pipeline output

October 01, 2012

A Bernstein Research report shows that, essentially, "Pipeline success rates across all phases of development have been slowly worsening or at best staying flat, depending on the phase (preclinical through registration)."

« Previous

Web Exclusive

Angelina Jolie's fearless but flawed message

Paul Oestreicher, Ph.D. May 17, 2013

Angelina Jolie's story raises important questions about education, outreach and access—but her nod to holistic treatments is less helpful

Podcasts

How to engage even the busiest physicians

March 04, 2013

Sponsored by TRUE Health + Wellness. The increasingly demanding schedules of healthcare professionals continue to narrow the window of opportunity for pharma sales teams, and, as a result, marketers are focusing more on non-personal promotion. However, there's a lot more to it than simply bombarding physicians with brand messages, as Anne Stroup, Managing Director at TRUE Health + Wellness, explains to MM&M's James Chase in this special podcast presentation.

2013 Hall of Fame Inductees

An entertaining look at the extraordinary lives and careers of the Medical Advertising Hall of Fame's 2013 inductees: Peter Frishauf, Dorothy Philips and David Labson. Clips produced by JUICE Pharma.